Oğuz Tekin

Oğuz Tekin

Auto-generated profile, based on publicly available information

Oğuz Tekin

ANKARA EĞİTİM VE ARAŞTIRMA HASTANESİ, AİLE HEKİMLİĞİ

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2004 in Archives of Disease in Childhood
Verified
Journal Article
Open access
PDF file
ZAZ Avci
Z Avci
AKA Koktener
A Koktener
NUN Uras
N Uras
FCF Catal
F Catal
AKA Karadag
A Karadag
EBE Baskin
E Baskin
Background: Background: Ceftriaxone, a third generation cephalosporin, is widely used for treating infection during childhood. The kidneys eliminate approximately 33–67% of this agent, and the remainder is eliminated via the biliary system. Ceftriaxone may bind with calcium ions and form insoluble precipitate leading to biliary pseudolithiasis. The aim of this study was to assess whether ceftriaxone associated nephrolithiasis develops by the same mechanism, and whether this condition is dose related. Methods: The study involved 51 children with various infections. Of these, 24 were hospitalized with severe infection and received 100 mg/kg/day ceftriaxone divided into two equal intravenous doses. The other 27 patients received a single daily intramuscular injection of 50 mg/kg/day. Serum and urine parameters were evaluated before and after treatment, and abdominal ultrasonographic examinations were also carried out before and after treatment. Results: Serum urea, creatinine, and calcium levels were normal in all patients before and after treatment. Post-treatment ultrasound identified nephrolithiasis in four (7.8%) of the 51 subjects. The stones were all of small size (2 mm). Comparison of the groups with and without nephrolithiasis revealed no significant differences with respect to age, sex distribution, duration of treatment, or dose/route of administration of ceftriaxone. The renal stones disappeared spontaneously in three of the four cases, but were still present in one patient 7 months after ceftriaxone treatment. Conclusions: Conclusions: The study showed that children taking a 7 day course of normal or high dose ceftriaxone may develop small sized asymptomatic renal stones. The overall incidence of nephrolithiasis in this study was 7.8%.

20 September 2006 in Techniques in Coloproctology
Verified
Journal Article
Closed access
PDF file
AAA. Akgün
A. Akgün
SKS. Kuru
S. Kuru
CUC. Uraldi
C. Uraldi
OTO. Tekin
O. Tekin
BKB. Karip
B. Karip
AÖA. U. Öngören
A. U. Öngören

1 December 2004
Verified
Journal Article
Closed access
ATAyşe Tunca
Ayşe Tunca
CTCansel Türkay
Cansel Türkay
OTOğuz Tekin
Oğuz Tekin
AKAyşe Kargili
Ayşe Kargili
MEMustafa Erbayrak
Mustafa Erbayrak

22 June 2013 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
IŞIrfan Şencan
Irfan Şencan
OTOğuz Tekin
Oğuz Tekin
MTMustafa Mansur Tatli
Mustafa Mansur Tatli

1 April 2002 in Mayo Clinic Proceedings
Verified
Journal Article
Closed access
OTOğuz Tekin
Oğuz Tekin

1 November 2004 in European Neurology
Verified
Journal Article
Closed access
OTOğuz Tekin
Oğuz Tekin
SÇSerdar Çukur
Serdar Çukur
CUCem Uraldı
Cem Uraldı
BIBünyamin Işık
Bünyamin Işık
AÖAdem Özkara
Adem Özkara
IÜIhsan Üstün
Ihsan Üstün
Background: The relationship between hypertension and cognitive impairment has been investigated in the literature; several clinical studies suggested a relationship between hypertension and retinopathy. Methods: We examined the relationship between the retinopathy status and cognitive functions by using the Mini-Mental State Examination (MMSE) among hypertensive subjects older than 40 years who were admitted to our Family Medicine, Internal Medicine and Ophthalmology clinics. The subjects were categorized into three groups: group 1 = control subjects (n = 39), group 2 = hypertensive patients without retinopathy (n = 32), and group 3 = hypertensive patients with retinopathy (n = 25). Results: The number of patients with total MMSE scores less than 24 was distributed as follows: group 1: 3 patients (7.7%), group 2: 4 patients (12.5%), and group 3: 14 patients (56%). Hypertension was found to be related with a significant decrease in total MMSE scores in comparison with group 1 subjects (p < 0.001). Furthermore, retinopathy significantly correlated with lower MMSE scores among hypertensive patients (p = 0.001). Compared with group 1, group 3 showed a significant decrease in orientation (p = 0.001), registration (p = 0.001), attention and calculation (p = 0.004), recall (p = 0.009), and total (p < 0.001) MMSE scores. We also found a significant decrease in recall (p = 0.032) and total (p = 0.034) scores in group 3 when compared with group 2. There was a significant decrease in registration (p = 0.002) and total (p = 0.029) MMSE scores in group 2 when compared with group 1. We also observed negative correlations between duration of the disease and orientation (R = –0.597, n = 32, p = 0.001), and between duration of the disease and total (R = –0.495, n = 32, p = 0.006) scores in group 2. Conclusions: Hypertension was found to be related with a decline in MMSE scores. This relation was even more significant in the group of hypertensive patients with retinopathy. Thus, we suggest that cognitive tests be routinely used in the follow-up of hypertensive patients.